NASDAQ: VIRX - Viracta Therapeutics, Inc.

Yield per half year: -89.61%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Viracta Therapeutics, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Viracta Therapeutics, Inc.

Viracta Therapeutics, Inc., компания по прецизионной онкологии, занимается разработкой лекарств для лечения злокачественных новообразований, связанных с вирусом. Он разрабатывает нанатиностат, пероральную комбинированную терапию в сочетании с противовирусным агентом валганцикловиром, который находится во II фазе клинических испытаний для вич-положительной лимфомы Эпштейна-Барра. Компания была основана в 2007 году со штаб-квартирой в Кардиффе, штат Калифорния.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2005-09-27
ISIN US92765F1084
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт http://www.viracta.com
Цена ао 0.0229
Change price per day: -14.55% (0.0268)
Change price per week: -13.58% (0.0265)
Change price per month: -21.03% (0.029)
Change price per 3 month: -90.84% (0.25)
Change price per half year: -89.61% (0.2205)
Change price per year: -97.88% (1.08)
Change price per 3 year: -99.54% (4.93)
Change price per 5 year: -94.81% (0.4411)
Change price per year to date: -90.16% (0.2327)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 1.05 9
P/E 2.74 10
EV/EBITDA -0.6484 0
Total: 6.13

Efficiency

Title Value Grade
ROA, % -90.06 0
ROE, % -278.72 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.5091 10
Total: 8

Growth impulse

Title Value Grade
Yield Revenue, % -95.27 0
Yield Ebitda, % 104.76 10
Yield EPS, % -51.7 0
Total: 5.8
More

Institutions Volume Share, %
BVF Inc. 3614662 9.2
Citadel Advisors Llc 1529072 3.89
Vanguard Group Inc 1161280 2.96
Samsara BioCapital, LLC 689709 1.76
Laurion Capital Management, LP 562995 1.43
MAI Capital Management 355460 0.91
Blackrock Inc. 305652 0.78
Aisling Capital Management LP 288571 0.73
Geode Capital Management, LLC 252701 0.64
Renaissance Technologies, LLC 178899 0.46



Head Job title Payment Year of birth
Mr. Mark Andrew Rothera CEO, President & Director 365.03k 1963 (62 years)
Dr. Ayman El-Guindy Chief Scientific Officer N/A
Dr. Darrel P. Cohen M.D., Ph.D. Chief Medical Officer N/A 1965 (60 years)
Dr. Susan Perrine M.D. Scientific Founder and Consultant
Dr. Ronald J. Berenson M.D. Co-Founder and Consultant 1952 (73 years)
Mr. George Hillman Co-Founder
Dr. Thalia Papayannopoulou M.D. Co-Founder
Dr. Robert M. Williams Ph.D. Co-Founder 1955 (70 years)
Dr. Douglas V. Faller M.D., Ph.D. Scientific Founder & Chairman of Scientific Advisory Board
Mr. Michael Eric Faerm Chief Financial Officer 1967 (58 years)

Address: United States, Cardiff-by-the-Sea, CA , 2533 South Coast Highway 101 - open in Google maps, open in Yandex maps
Website: http://www.viracta.com